rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTAPH Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09
Sources of funds
Owner's fund
Equity share capital 11.80 11.80 11.80 11.80 11.80
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 344.48 260.04 203.75 164.11 140.35
Loan funds
Secured loans 107.70 148.23 126.93 181.52 200.86
Unsecured loans 15.76 14.00 31.35 21.77 39.37
Total 479.74 434.06 373.83 379.20 392.37
Uses of funds
Fixed assets
Gross block 403.11 348.48 290.34 221.76 171.61
Less : revaluation reserve - - - - -
Less : accumulated depreciation 140.38 111.92 84.15 60.91 41.42
Net block 262.73 236.56 206.19 160.85 130.19
Capital work-in-progress 12.49 2.51 17.22 46.99 55.17
Investments 18.86 17.05 17.05 17.05 17.05
Net current assets
Current assets, loans & advances 381.30 362.72 240.40 240.91 257.12
Less : current liabilities & provisions 195.64 184.79 107.02 86.60 67.16
Total net current assets 185.66 177.93 133.37 154.30 189.96
Miscellaneous expenses not written - - - - -
Total 479.74 434.06 373.83 379.20 392.37
Notes:
Book value of unquoted investments 18.86 17.05 17.05 17.05 17.05
Market value of quoted investments - - - - -
Contingent liabilities 83.39 28.87 16.81 10.43 24.85
Number of equity sharesoutstanding (Lacs) 234.17 117.09 117.09 117.09 117.09
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close